Week 275 Review - Back above £100K after a great week

It's great when the portfolio has a good week across the board and OPTI:Optibiotix has a tick up too, as then we get a really healthy spike up. The deficit between cost and value narrowed by £7,689 to £24,175 and combined portfolio value went back above £100K at £100,512.

There was only one big loser this week, as CMCL:Caledonia Mining dropped 7%. I'm not sure why as their results were pretty good. I suspect gold stocks have dipped as people switch back to normal equities. These are 16% down now and the worst performing of my magic formula shares.

CAML:Central Asia Metals finally announced the reinstatement of their dividend. It was reduced a tiny bit, but 6p is still 3.2% and this is only the interim dividend. It should give me £346 which is nice. The response was more muted than I hoped, but the share price is still up 5% and they are £20 from being back in profit.

IES:Invinity Energy climbed 5% after announcing a new project to supply European Marine Energy Centre (EMEC) with flow batteries for their tidal power to hydrogen project. I thought these were a goner when RED:RedT Energy gave up, but there does seem to be a flicker of hope after the merger. They are still 75% down though.

RDT:Rosslyn Data announced a new contract win and that saw them climb by 6%. They seem to have jumped on a Brexit bandwagon. The RNS describes it as a system that allows their client to "receive, manage and discharge duty suspended shipments from authorised suppliers under the Excise movement and control system (EMCS)". Hopefully there will be big demand for this post-Brexit as it's the sort of thing that could cause a major turn-around. They are still 67% down, but this was a very small investment so it's not a big dent on the portfolio.

TLOU:Tlou Energy are still climbing steadily, with another 6% rise this week. They are now just 46% down, so things are looking up. The 8,809 I bought in the open offer at 2.2p are looking great now the price is 4p.

PAY:Paypoint got hammered after news they were being investigated for competition law infringement. That seems to have been forgotten as they claw their way back. I think last week's announcement of the acquisition of Handepay and Merchant Rentals is sinking in and aiding the recovery. They climbed 7% this week and are only 4% down now.

APAX:Apax Global Alpha have been doing really well lately, and this week was no exception as they climbed 9% to go 17% up and confirm my belief in the magic formula system. I'd never even heard of them before they popped up near the top of my spreadsheet.

OPTI:Optibiotix have had a miserable few weeks, but the brakes came off and they were allowed to climb 5p. That resulted in an 8% rise and means they are only 15% down. Sometimes when the brakes come off they stay off for a week or two until we hit 67p. Then the traders start selling back down to 50p. That's been going on for years, but one day we'll break out of the cycle.

JLP:Jubilee Metals just misses out on Share of the Week for the 2nd week in a row. Their march upwards is relentless, and audited results this week showed earnings of £18.3m from revenue of £54.8m. That's before copper production comes on line. I shudder to think what next year's figures will look like, but there may be a dividend coming. This week they climbed 16% and are up by 76% and making £3,272 potential profit. I'm still glad I top-sliced 30% of my holding, although I would have made an extra £500 if I'd waited until now.

Share of the Week is ITV:ITV which gave a Q3 trading update this week. The price had risen in anticipation, and fortunately didn't fall after the event. They climbed 19% and are up by 30% in the short time I've owned them. The great thing about the magic formula system is that I'm not even slightly tempted to take the profit, as the rules state I have to hold them for 12 months. Temptation is much easier to resist when you have rules.

Back up to the £100K line which I never seem to hang onto for long.

I'm glad that was a very short stay below the trend line. lets hope we can start dragging it upwards now.

The ISA and share portfolios look like this

			Weekly Change
Cash	£9.70		+£0
Portfolio cost	£62,990.04		+£0
Portfolio sell value (bid price-commission)	£49,797.72	(-20.9%)	+£4,550.24
Potential profits	£3,272.05		+£700.00
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 Average monthly cash profit	£166.63	(3.2%)	-£11.91
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£348.46	(6.6%)	-£1.27
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	10.0%		-0.1%
Compound performance	53%		+0%

£700 rise in potential profit thanks to JLP:Jubilee Metals and a generally healthy picture as the value climbs by £4,550.

I ought to get nervous whenever the green line reaches this point.

Back above the trend line, and it wouldn't take much more to be in the best position for a year.
The SIPP looks like this after week 259

		Weekly Change
Cash	£138.65		+£0
Portfolio cost	£58,959.20		+£0
Portfolio sell value (bid price - commission)	£48,729.45	(-17.4%)	+£3,146.30
Potential profits	£731.53		+£293.96
Yr 5 Dividends	£167.84		+£0
Yr 5 Interest	£0.03		+£0
Yr 5 Profit from sales	£2,910.34		+£0
Yr 5 Average monthly cash profit	£246.46	(5.0%)	-£4.93
Total Dividends	£2,067.08		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£15,459.44		+£0
Average monthly cash profit	£282.85	(5.8%)	-£1.10
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	8.9%		-0.1%
Compound performance	45%		+0%

Nice to see a small rise in potential profits as the magic formula shares creep upwards, and a socking great improvement in value mostly thanks to OPTI:Optibiotix. Rather annoyed that my 17.2p purchase of SBTX:SkinBioTherapeutics could have been made at 15.25p if I'd waited a few weeks. These are down 18% and losing £734 in just a few weeks.

There's only 1 week to go until the end of year 5. I'm certain not to be selling anything next week so it looks like I'll achieve a 5% return against portfolio cost. That's 7.8% against injection amount, so although below my 10% target it's not bad considering it's been a mad year.

Just about closer to the cost line than the injection line now. Given the cost line has gone up, I ought to be able to get above this level that I keep bouncing back down from.

This shows that we're still quite a way from the usual resistance point as the costs have increased from re-investment. Good to be back above the trend line.

The trading account looks like this after week 225

			Weekly Change
Cash	£236.18		+£0
Portfolio cost	£2,354.11		+£0
Portfolio sell value (bid price - commission)	£1,600.61	(-32.0%)	-£7.16
Potential profits	£0		+£0
Year 5 Dividends	£0		+£0
Year 5 Profit	£370.12		+£0
Yr 5 Average monthly cash profit	£94.34	(48.1%)	-£5.90
Dividends	£47.92		+£0
Profit from sales	£656.49		+£0
Average monthly cash profit	£13.57	(6.9%)	-£0.06
(Sold stocks profit + Dividends - Fees  / Months)

Very little change here, but a slight tick down in value. Still seems likely to be a long time until I can sell anything.

Staying above the injection line.

Running reasonably parallel to the trend line and fortunately still above it.

Here's my wish list:

1. TLOU:Tlou Energy announce de-watering has resumed. Not yet, but still we climb.
2. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operational. They are distracting us with results and things - but still no sign of these announcements.
3. OPTI:Optibiotix to get within 10% of profit. Not far to go now, as long as the seller doesn't return.
   
4. CAML:Central Asia Metals re-instate their dividend. Yes! Very happy about this and I can close this wish now.

Pay day this weekend and my pension contribution should go in towards the end of the week. It should take me over the £2,200 I need in order to transfer out £2,000 and leave £200 behind. I'll be adding the cash to my new AJ Bell account as I look to spread my risk across a few brokers. With OPTI:Optibiotix on the rise it's looking like SBTX:SkinBioTherapeutics will be my target. If that goes up before the cash arrives I'll either get back into DDDD:4D Pharma or pick out my next 2 magic formula shares.